0001104659-22-128766.txt : 20221220 0001104659-22-128766.hdr.sgml : 20221220 20221220200050 ACCESSION NUMBER: 0001104659-22-128766 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221216 FILED AS OF DATE: 20221220 DATE AS OF CHANGE: 20221220 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bernstein Bruce CENTRAL INDEX KEY: 0001665472 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40458 FILM NUMBER: 221476299 MAIL ADDRESS: STREET 1: 780 THIRD AVENUE, 12TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Synaptogenix, Inc. CENTRAL INDEX KEY: 0001571934 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 461585656 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1185 AVENUE OF THE AMERICAS, 3RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 BUSINESS PHONE: 9732420005 MAIL ADDRESS: STREET 1: 1185 AVENUE OF THE AMERICAS, 3RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 FORMER COMPANY: FORMER CONFORMED NAME: NEUROTROPE BIOSCIENCE, INC. DATE OF NAME CHANGE: 20130312 4 1 tm2233089-2_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2022-12-16 0 0001571934 Synaptogenix, Inc. SNPX 0001665472 Bernstein Bruce C/O SYNAPTOGENIX, INC., 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 1 0 0 0 Common Stock, par value $0.0001 per share 2022-12-16 4 S 0 22500 1.1719 D 27578 D Shares sold pursuant to a Rule 10b5-1 sales plan, entered into on December 6, 2021 and amended and restated on October 24, 2022, to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. /s/ Robert Weinstein, Attorney-in-fact 2022-12-20